Standards and Best Practice for Acute Normovolemic Hemodilution: Evidence-based Consensus Recommendations.

acute normovolemic hemodilution blood transfusion cardiac surgery cardiopulmonary bypass guidelines recommendations

Journal

Journal of cardiothoracic and vascular anesthesia
ISSN: 1532-8422
Titre abrégé: J Cardiothorac Vasc Anesth
Pays: United States
ID NLM: 9110208

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 08 01 2020
accepted: 11 01 2020
pubmed: 5 3 2020
medline: 28 4 2021
entrez: 5 3 2020
Statut: ppublish

Résumé

To develop a standardized approach to the implementation and performance of acute normovolemic hemodilution (ANH) in order to reduce the incidence of bleeding and allogeneic blood transfusion in high-risk surgical bleeding-related cardiac surgery with cardiopulmonary bypass (CPB). A 2-round modified RAND-Delphi consensus process. Seven physicians from multiple geographic locations and clinical disciplines including anesthesiology and cardiac surgery and 1 cardiac surgery perfusionist participated in the survey. One registered nurse, specializing in Patient Blood Management, participated in the discussion but did not participate in the survey. A modified RAND-Delphi method was utilized that integrated evidence review with a face-to-face expert multidisciplinary panel meeting, followed by repeated scoring using a 9-point Likert scale. Consensus was determined as a result from the second round survey, as follows: median rating of 1-3: ANH acceptable; median rating of 7-9: ANH not acceptable; median rating of 4-6: use clinical judgment. Evidentiary review identified 18 key peer-reviewed manuscripts for discussion. Through the consensus-building process, 39 statements including 26 contraindications to ANH and 10 CPB patient variables were assessed. In total, 22 statements were accepted or modified for the second scoring round. Consensus was reached on 6 conditions in which ANH would or would not be acceptable, showing that development of a standardized approach for the use of ANH in high-risk surgical bleeding and allogeneic blood transfusion is clearly possible. The recommendations developed by this expert panel may help guide the management and inclusion of ANH as an evidence and consensus-based blood conservation modality.

Identifiants

pubmed: 32127266
pii: S1053-0770(20)30080-X
doi: 10.1053/j.jvca.2020.01.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1755-1760

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Auteurs

Aryeh Shander (A)

TeamHealth Research Institute, Englewood, NJ; Englewood Health, Englewood, NJ; Icahn School of Medicine, New York, NY; Rutgers University, Newark, NJ. Electronic address: Aryeh.Shander@EHMCHealth.org.

James Brown (J)

NorthShore University Health System, Evanston, IL.

Marc Licker (M)

University Hospital, University of Geneva, Geneva, Switzerland.

David C Mazer (DC)

University of Toronto at St. Michaels Hospital, Toronto, Ontario, Canada.

Jens Meier (J)

Kepler University Hospital, Linz, Austria.

Sherri Ozawa (S)

Englewood Hospital and Medical Center, Englewood, NJ.

Pierre R Tibi (PR)

Yavapai Regional Medical Center, Prescott, AZ.

Phillipe Van der Linden (P)

CHU Brugmann, HUDERF, Université Libre de Bruxelles, Brussels, Belgium.

Seth Perelman (S)

NYU School of Medicine, New York, NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH